Corcept Therapeutics (CORT) Times Interest Earned (2010 - 2026)
Corcept Therapeutics (CORT) reported Times Interest Earned of -$4.32 for Q1 2026, down 1173.11% on a YoY basis from $0.4 in Q1 2025, and down 100.19% sequentially from $2243.5 in Q4 2025.
Corcept Therapeutics (CORT) Times Interest Earned (2010 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 17 years of Times Interest Earned data on file, last reported at -$4.32 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 1173.11% year-over-year to -$4.32; the trailing twelve-month figure through Mar 2026 stood at -$0.72 (down 105.48% YoY), and the FY2025 full-year result was $192.26, up 212.78% from the prior year.
- Times Interest Earned eased to -$4.32 in Q1 2026, from $2243.5 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $2243.5 in Q4 2025 to a low of -$4.32 in Q1 2026.
- A 5-year average of $141.41 and a median of $3.88 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 4598.01% in 2025 and sank 1173.11% in 2026, its largest moves.
- Tracing CORT's Times Interest Earned over 5 years: stood at $9.93 in 2022, then soared by 33.34% to $13.25 in 2023, then jumped by 260.54% to $47.75 in 2024, then surged by 4598.01% to $2243.5 in 2025, then tumbled by 100.19% to -$4.32 in 2026.
- Business Quant data shows CORT's Times Interest Earned at -$4.32 in Q1 2026, $2243.5 in Q4 2025, and $1.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn | -4.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.32 |
| Dec 31, 2025 | 2,243.50 |
| Sep 30, 2025 | 1.32 |
| Jun 30, 2025 | 16.21 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 47.75 |
| Sep 30, 2024 | 5.34 |
| Jun 30, 2024 | 4.08 |
| Mar 31, 2024 | 47.81 |
| Dec 31, 2023 | 13.25 |
| Sep 30, 2023 | 3.00 |
| Jun 30, 2023 | 2.99 |
| Mar 31, 2023 | 1.60 |
| Dec 31, 2022 | 9.93 |
| Sep 30, 2022 | 3.80 |
| Jun 30, 2022 | 3.88 |
| Mar 31, 2022 | 3.48 |
| Dec 31, 2021 | 509.22 |
| Sep 30, 2021 | 5.03 |
| Jun 30, 2021 | 4.77 |